SomnoMed Limited
SOMNF
$0.4361
-$0.0487-10.05%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 17.50M | 17.99M | 15.33M | 15.30M | 14.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.50M | 17.99M | 15.33M | 15.30M | 14.70M |
| Cost of Revenue | 6.72M | 6.91M | 6.42M | 6.40M | 5.56M |
| Gross Profit | 10.78M | 11.09M | 8.92M | 8.90M | 9.15M |
| SG&A Expenses | 9.37M | 9.63M | 9.22M | 9.20M | 9.67M |
| Depreciation & Amortization | 955.50K | 982.50K | 946.40K | 944.50K | 945.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.04M | 17.52M | 16.58M | 16.55M | 16.17M |
| Operating Income | 460.80K | 473.80K | -1.25M | -1.25M | -1.47M |
| Income Before Tax | 490.70K | 504.60K | -1.89M | -1.88M | -1.81M |
| Income Tax Expenses | 525.10K | 540.00K | 56.00K | 55.90K | 261.00K |
| Earnings from Continuing Operations | -34.40K | -35.40K | -1.94M | -1.94M | -2.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -34.40K | -35.40K | -1.94M | -1.94M | -2.07M |
| EBIT | 460.80K | 473.80K | -1.25M | -1.25M | -1.47M |
| EBITDA | 998.90K | 1.03M | -951.40K | -949.40K | -937.50K |
| EPS Basic | 0.00 | 0.00 | -0.01 | -0.01 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | -0.01 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 211.08M | 211.08M | 147.96M | 147.96M | 93.48M |
| Average Diluted Shares Outstanding | 211.08M | 211.08M | 147.96M | 147.96M | 93.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |